1. Elliott, P, Andersson, B, Arbustini, E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29: 270–276.
Google Scholar | Crossref | Medline | ISI2. Seferović, PM, Polovina, M, Bauersachs, J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21: 553–576.
Google Scholar | Crossref3. Arzilli, C, Aimo, A, Vergaro, G, et al. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure. Eur J Prev Cardiol 2018; 25: 889–895. DOI: 10.1177/2047487318766580.
Google Scholar | SAGE Journals | ISI4. Corrà, U, Agostoni, P, Giordano, A, et al. The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. Int J Cardiol 2016; 203: 1067–1072.
Google Scholar | Crossref | Medline | ISI5. Guazzi, M. Cardiopulmonary exercise testing and risk stratification in heart failure with reduced, midrange or preserved ejection fraction: when nomenclature may not match with pathophysiology. Eur J Prev Cardiol 2018; 25: 392–394. DOI: 10.1177/2047487317748456.
Google Scholar | SAGE Journals | ISI6. Van Iterson, EH, Kim, CH, Uithoven, K, et al. Obesity and hemoglobin content impact peak oxygen uptake in human heart failure. Eur J Prev Cardiol 2018; 25: 1937–1946.
Google Scholar | SAGE Journals | ISI7. Stelken, AM, Younis, LT, Jennison, SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996; 27: 345–352.
Google Scholar | Crossref | Medline | ISI8. Sinagra, G, Iorio, A, Merlo, M, et al. Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy. Int J Cardiol 2016; 223: 596–603.
Google Scholar | Crossref | Medline9. Sinagra G, Merlo M, Pinamonti B (eds). Dilated Cardiomyopathy: From Genetics to Clinical Management. Springer 2019, pp. 187–198.
Google Scholar10. Hirashiki, A, Kondo, T, Okumura, T, et al. Cardiopulmonary exercise testing as a tool for diagnosing pulmonary hypertension in patients with dilated cardiomyopathy. Ann Noninvasive Electrocardiol 2016; 21: 263–271.
Google Scholar | Crossref | Medline11. Ware, JS, Amor-Salamanca, A, Tayal, U, et al. Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol 2018; 71: 2293–2302.
Google Scholar | Crossref | Medline12. Huizar, JF, Ellenbogen, KA, Tan, AY, et al. Arrhythmia-induced cardiomyopathy. J Am Coll Cardiol 2019; 73: 2328–2344.
Google Scholar | Crossref | Medline13. Zamorano, JL, Anastasakis, A, Borger, MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779.
Google Scholar | Crossref | Medline14. Magrì, D, Santolamazza, C. Cardiopulmonary exercise test in hypertrophic cardiomyopathy. Ann Am Thorac Soc 2017; 14: S102–S109.
Google Scholar | Crossref | Medline15. Magrì, D, Agostoni, P, Sinagra, G, et al. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. Int J Cardiol 2018; 271: 125–131.
Google Scholar | Crossref | Medline16. Sharma, S, Elliott, P, Whyte, G, et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol 2000; 86: 162–168.
Google Scholar | Crossref | Medline17. Jones, S, Elliott, PM, Sharma, S, et al. Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart 1998; 80: 60–67.
Google Scholar | Crossref | Medline18. Muchtar, E, Blauwet, LA, Gertz, MA. Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 2017; 121: 819–837.
Google Scholar | Crossref | Medline19. Sayegh, ALC, dos Santos, MR, de Oliveira, P, et al. Characterization of cardiopulmonary exercise testing variables in patients with endomyocardial fibrosis after endocardial resection. Arq Bras Cardiol 2017; 109: 533–540.
Google Scholar | Medline20. Sayegh, ALC, dos Santos, MR, Sarmento, AO, et al. Cardiac and peripheral autonomic control in restrictive cardiomyopathy. ESC Heart Fail 2017; 4: 341–350.
Google Scholar | Crossref | Medline21. Reddy, YNV, Olson, TP, Obokata, M, et al. Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. JACC Heart Fail 2018; 6: 665–675.
Google Scholar | Crossref | Medline22. Pinamonti, B. Arrhythmogenic right ventricular cardiomyopathy: from genetics to diagnostic and therapeutic challenges. World J Cardiol 2014; 6: 1234.
Google Scholar | Crossref | Medline23. Corrado, D, Basso, C, Judge, DP. Arrhythmogenic cardiomyopathy. Circ Res 2017; 121: 785–802.
Google Scholar | Crossref24. Scheel, PJ, Florido, R, Hsu, S, et al. Safety and utility of cardiopulmonary exercise testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Heart Assoc 2020; 9: e013695.
Google Scholar | Crossref | Medline25. Guazzi, M, Villani, S, Generati, G, et al. Right ventricular contractile reserve and pulmonary circulation uncoupling during exercise challenge in heart failure: pathophysiology and clinical phenotypes. JACC Heart Fail 2016; 4: 625–635.
Google Scholar | Crossref | Medline26. Masri, A, Pierson, L, Smedira, NG, et al. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. Am Heart J 2015; 169: 684–692.
Google Scholar | Crossref | Medline27. Magrì, D, Limongelli, G, Re, F, et al. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy. Heart 2016; 102: 602–609.
Google Scholar | Crossref | Medline28. Finocchiaro, G, Haddad, F, Knowles, JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. J Am Coll Cardiol Heart Fail 2015; 3: 408–418.
Google Scholar29. Coats, CJ, Rantell, K, Bartnik, A, et al. Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy. Circ Heart Fail 2015; 8: 1022–1031.
Google Scholar | Crossref | Medline30. Magrì, D, Agostoni, P, Sinagra, G, et al. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. Int J Cardiol 2018; 271: 125–131.
Google Scholar | Crossref | Medline